$GILD Recent Headlines Hopes for single-dose H
Post# of 44860
Posted On: 02/11/2015 9:54:21 AM
$GILD Recent Headlines
Hopes for single-dose Hepatitis C drug fade 3:30 p.m. Feb. 9, 2015 - Russ Britt
McKesson revenue buoyed by Hep C drugs 4:54 p.m. Feb. 5, 2015 - MarketWatch.com
The best way to get into the drug-distribution space 1:20 p.m. Feb. 5, 2015 - The Trading Deck
Keurig Green Mountain burned by weak outlook, sales 6:35 p.m. Feb. 4, 2015 - Sue Chang
U.S. stocks end lower as ECB reject Greek bonds as collateral 4:33 p.m. Feb. 4, 2015 - Barbara Kollmeyer
Gilead to discount its pricey Sovaldi drug 1:55 p.m. Feb. 4, 2015 - Russ Britt
Gilead Sciences shares tumble 9.7% 9:33 a.m. Feb. 4, 2015 - Sue Chang
Careful what you wish for: Oil-price recovery may sting 8:28 a.m. Feb. 4, 2015 - Shawn Langlois
Disney shares rise after earnings beat 6:20 p.m. Feb. 3, 2015 - Sue Chang
Gilead earnings beat views by 20 cents a share 4:32 p.m. Feb. 3, 2015 - Russ Britt
Updates, advisories and surprises 4:31 p.m. Feb. 3, 2015 - MarketWatch
Gilead Sciences profit surges on Hep-C drugs 4:20 p.m. Feb. 3, 2015 - MarketWatch.com
Gilead earnings beats views by 20 cents a share 4:18 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. of $7.3B beats view of $6.72B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. $7.32B vs. year-ago $3.12B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead adj. earns $2.43/share vs. $2.23/share view 4:07 p.m. Feb. 3, 2015 - Russ Britt
What to look for in Gilead earnings 11:26 a.m. Feb. 3, 2015 - Russ Britt
Bulls looking for a lift as things aren’t going by the playbook 6:39 a.m. Feb. 3, 2015 - Shawn Langlois
Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price 50 min ago - TheStreet.com
Short Sellers Look Scared of Big Biotech 8:52 a.m. Today - 247WallSt.com
No Overseas Noise Is Good For America - Cramer's Mad Money (2/10/15) 7:38 a.m. Today - Seeking Alpha
InsiderInsights.com Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK 4:29 a.m. Today - Seeking Alpha
The Dividend Growth 50... Plus 111 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
The Dividend Growth 50... Plus 113 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial 11:36 a.m. Feb. 10, 2015 - GuruFocus.com
Gilead Walloped by Lower Pricing View on Hepatitis C 10:59 a.m. Feb. 10, 2015 - Barrons.com
Bad News For Gilead Sciences Is Great News For Investors 9:39 a.m. Feb. 10, 2015 - Seeking Alpha
Obama's Proposal To Allow Government To Negotiate Treatment Prices Creates New Questions For Drug Makers 7:55 a.m. Feb. 10, 2015 - benzinga.com
Total Return Of Stocks With The Largest Following On Seeking Alpha 7:42 a.m. Feb. 10, 2015 - Seeking Alpha
European charity uses legal challenge to improve access to Sovaldi 7:34 a.m. Feb. 10, 2015 - Seeking Alpha
Career Booster for CFOs: Work Experience Abroad 12:01 a.m. Feb. 10, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase 8:53 p.m. Feb. 9, 2015 - TheStreet.com
Going Overweight With Gilead In My DGI Portfolio 4:33 p.m. Feb. 9, 2015 - Seeking Alpha
Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News 3:38 p.m. Feb. 9, 2015 - Zacks.com
Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More 3:21 p.m. Feb. 9, 2015 - TheStreet.com
Gilead Sciences Could Be A Dividend Growth Stock 3:04 p.m. Feb. 9, 2015 - Seeking Alpha
Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown 10:46 a.m. Feb. 9, 2015 - benzinga.com
Regulus' Dream of a Single-Shot Hepatitis C Cure Falls Short 10:05 a.m. Feb. 9, 2015 - TheStreet.com
Patience Pays Off for Opko and Cocrystal Investors, Will It Also for Pershing Gold? 27 min ago - ACCESSWIRE
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 9, 2015 - BusinessWire - BZX
Mobiquity Invests $20 Million in London Healthcare, Joins London Mayor in MedCity Initiative and Gilead Sciences 1:07 p.m. Feb. 9, 2015 - Marketwired
Earnings Forecast Research for Alibaba, Frontier, Akamai Technologies, Gilead Sciences, Halliburton, and Freeport-McMoRan 8:45 a.m. Feb. 9, 2015 - PR Newswire - PRF
Health Care Leaders Call for Sustainable Pricing as Senate Health Committee Shines Spotlight on Six-Figure Specialty Drugs 4:51 p.m. Feb. 4, 2015 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Alibaba, Stratasys, Gilead Sciences, Cliffs Natural Resources, and Bank of America 8:45 a.m. Feb. 4, 2015 - PR Newswire - PRF
Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program 4:06 p.m. Feb. 3, 2015 - BusinessWire - BZX
Critical Alerts For Amazon.com, JetBlue, KB Home, Stratasys and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Jan. 30, 2015 - PR Newswire - PRF
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America 8:45 a.m. Jan. 29, 2015 - PR Newswire - PRF
Gilead Announces Executive Promotions 4:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 5:00 p.m. Jan. 27, 2015 - BusinessWire - BZX
EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C 1:00 p.m. Jan. 26, 2015 - BusinessWire - BZX
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent 10:58 a.m. Jan. 26, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year 1:06 p.m. Jan. 21, 2015 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Intel, Alibaba, Bank of America, Activision Blizzard, and Gilead Sciences 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert 6:15 a.m. Jan. 20, 2015 - Marketwired
Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM 8:45 a.m. Jan. 14, 2015 - PR Newswire - PRF
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 5:00 p.m. Jan. 12, 2015 - BusinessWire - BZX
Hopes for single-dose Hepatitis C drug fade 3:30 p.m. Feb. 9, 2015 - Russ Britt
McKesson revenue buoyed by Hep C drugs 4:54 p.m. Feb. 5, 2015 - MarketWatch.com
The best way to get into the drug-distribution space 1:20 p.m. Feb. 5, 2015 - The Trading Deck
Keurig Green Mountain burned by weak outlook, sales 6:35 p.m. Feb. 4, 2015 - Sue Chang
U.S. stocks end lower as ECB reject Greek bonds as collateral 4:33 p.m. Feb. 4, 2015 - Barbara Kollmeyer
Gilead to discount its pricey Sovaldi drug 1:55 p.m. Feb. 4, 2015 - Russ Britt
Gilead Sciences shares tumble 9.7% 9:33 a.m. Feb. 4, 2015 - Sue Chang
Careful what you wish for: Oil-price recovery may sting 8:28 a.m. Feb. 4, 2015 - Shawn Langlois
Disney shares rise after earnings beat 6:20 p.m. Feb. 3, 2015 - Sue Chang
Gilead earnings beat views by 20 cents a share 4:32 p.m. Feb. 3, 2015 - Russ Britt
Updates, advisories and surprises 4:31 p.m. Feb. 3, 2015 - MarketWatch
Gilead Sciences profit surges on Hep-C drugs 4:20 p.m. Feb. 3, 2015 - MarketWatch.com
Gilead earnings beats views by 20 cents a share 4:18 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. of $7.3B beats view of $6.72B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead revs. $7.32B vs. year-ago $3.12B 4:09 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead net is $2.18/share vs. year-ago 47 cents/share 4:08 p.m. Feb. 3, 2015 - Russ Britt
Gilead adj. earns $2.43/share vs. $2.23/share view 4:07 p.m. Feb. 3, 2015 - Russ Britt
What to look for in Gilead earnings 11:26 a.m. Feb. 3, 2015 - Russ Britt
Bulls looking for a lift as things aren’t going by the playbook 6:39 a.m. Feb. 3, 2015 - Shawn Langlois
Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price 50 min ago - TheStreet.com
Short Sellers Look Scared of Big Biotech 8:52 a.m. Today - 247WallSt.com
No Overseas Noise Is Good For America - Cramer's Mad Money (2/10/15) 7:38 a.m. Today - Seeking Alpha
InsiderInsights.com Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK 4:29 a.m. Today - Seeking Alpha
The Dividend Growth 50... Plus 111 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
The Dividend Growth 50... Plus 113 More 6:31 p.m. Feb. 10, 2015 - Seeking Alpha
Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial 11:36 a.m. Feb. 10, 2015 - GuruFocus.com
Gilead Walloped by Lower Pricing View on Hepatitis C 10:59 a.m. Feb. 10, 2015 - Barrons.com
Bad News For Gilead Sciences Is Great News For Investors 9:39 a.m. Feb. 10, 2015 - Seeking Alpha
Obama's Proposal To Allow Government To Negotiate Treatment Prices Creates New Questions For Drug Makers 7:55 a.m. Feb. 10, 2015 - benzinga.com
Total Return Of Stocks With The Largest Following On Seeking Alpha 7:42 a.m. Feb. 10, 2015 - Seeking Alpha
European charity uses legal challenge to improve access to Sovaldi 7:34 a.m. Feb. 10, 2015 - Seeking Alpha
Career Booster for CFOs: Work Experience Abroad 12:01 a.m. Feb. 10, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase 8:53 p.m. Feb. 9, 2015 - TheStreet.com
Going Overweight With Gilead In My DGI Portfolio 4:33 p.m. Feb. 9, 2015 - Seeking Alpha
Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News 3:38 p.m. Feb. 9, 2015 - Zacks.com
Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More 3:21 p.m. Feb. 9, 2015 - TheStreet.com
Gilead Sciences Could Be A Dividend Growth Stock 3:04 p.m. Feb. 9, 2015 - Seeking Alpha
Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown 10:46 a.m. Feb. 9, 2015 - benzinga.com
Regulus' Dream of a Single-Shot Hepatitis C Cure Falls Short 10:05 a.m. Feb. 9, 2015 - TheStreet.com
Patience Pays Off for Opko and Cocrystal Investors, Will It Also for Pershing Gold? 27 min ago - ACCESSWIRE
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 9, 2015 - BusinessWire - BZX
Mobiquity Invests $20 Million in London Healthcare, Joins London Mayor in MedCity Initiative and Gilead Sciences 1:07 p.m. Feb. 9, 2015 - Marketwired
Earnings Forecast Research for Alibaba, Frontier, Akamai Technologies, Gilead Sciences, Halliburton, and Freeport-McMoRan 8:45 a.m. Feb. 9, 2015 - PR Newswire - PRF
Health Care Leaders Call for Sustainable Pricing as Senate Health Committee Shines Spotlight on Six-Figure Specialty Drugs 4:51 p.m. Feb. 4, 2015 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Alibaba, Stratasys, Gilead Sciences, Cliffs Natural Resources, and Bank of America 8:45 a.m. Feb. 4, 2015 - PR Newswire - PRF
Gilead Sciences Announces 43 Cents Quarterly Dividend Program and $15 Billion Share Buyback Program 4:06 p.m. Feb. 3, 2015 - BusinessWire - BZX
Critical Alerts For Amazon.com, JetBlue, KB Home, Stratasys and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Jan. 30, 2015 - PR Newswire - PRF
Earnings Forecast Buzz for Fannie Mae, Apple, Yahoo, Alibaba, Gilead Sciences, and Bank of America 8:45 a.m. Jan. 29, 2015 - PR Newswire - PRF
Gilead Announces Executive Promotions 4:30 p.m. Jan. 28, 2015 - BusinessWire - BZX
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015 5:00 p.m. Jan. 27, 2015 - BusinessWire - BZX
EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C 1:00 p.m. Jan. 26, 2015 - BusinessWire - BZX
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent 10:58 a.m. Jan. 26, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year 1:06 p.m. Jan. 21, 2015 - PR Newswire - PRF
Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
Earnings Forecast Research for Apple, Intel, Alibaba, Bank of America, Activision Blizzard, and Gilead Sciences 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert 6:15 a.m. Jan. 20, 2015 - Marketwired
Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM 8:45 a.m. Jan. 14, 2015 - PR Newswire - PRF
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 5:00 p.m. Jan. 12, 2015 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼